Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$72.62 - $79.98 $1.83 Million - $2.02 Million
-25,220 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$61.48 - $73.72 $67,628 - $81,092
-1,100 Reduced 4.18%
25,220 $1.84 Million
Q4 2021

Jan 20, 2022

BUY
$53.63 - $62.52 $1.41 Million - $1.65 Million
26,320 New
26,320 $1.64 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $2.35 Million - $2.75 Million
-39,731 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $2.46 Million - $2.68 Million
39,731 New
39,731 $2.65 Million
Q2 2020

Jul 29, 2020

SELL
$54.82 - $64.09 $1.41 Million - $1.64 Million
-25,639 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $53,406 - $77,611
-1,151 Reduced 4.3%
25,639 $1.43 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $42,770 - $50,710
1,000 Added 3.88%
26,790 $1.36 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $98,164 - $108,548
2,200 Added 9.33%
25,790 $1.17 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $1.04 Million - $1.24 Million
23,006 Added 3939.38%
23,590 $1.13 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $292 - $379
-6 Reduced 1.02%
584 $30,000
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $280,485 - $322,895
-4,681 Reduced 88.81%
590 $37,000
Q4 2017

May 08, 2018

BUY
$59.94 - $65.35 $315,943 - $344,459
5,271
5,271 $323,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Claybrook Capital, LLC Portfolio

Follow Claybrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claybrook Capital, LLC with notifications on news.